S. Scott

Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.

A. Talhouk, S. Leung, D. Huntsman, 2022, Gynecologic oncology.

Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.

A. Talhouk, M. Köbel, D. Provencher, 2020, Gynecologic oncology.

Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes.

A. Tinker, M. Köbel, D. Provencher, 2020, Gynecologic oncology.

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.

A. Talhouk, S. Leung, D. Huntsman, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.

A. Talhouk, S. Leung, D. Huntsman, 2023, Gynecologic oncology.

Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification

A. Talhouk, S. Leung, A. Tinker, 2022, Modern Pathology.

Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.

J. Kwon, C. McGahan, E. Cai, 2017, Gynecologic oncology.

OP015/#492 Further stratification of no specific molecular profile (NSMP/P53WT) endometrial carcinomas to refine prognosis and identify therapeutic opportunities

A. Talhouk, M. Köbel, C. Gilks, 2021, Oral Featured Posters.